Baculovirus p 33 Binds Human p 53 and Enhances p 53-Mediated Apoptosis

In vertebrates, p53 participates in numerous biological processes including cell cycle regulation, apoptosis, differentiation, and oncogenic transformation. When insect SF-21 cells were infected with a recombinant of the baculovirus Autographa californica nuclear polyhedrosis virus (AcMNPV) overexpressing human p53, p53 formed a stable complex with the product of the AcMNPV orf92, a novel protein p33. The interaction between p53 and p33 was further confirmed by immunoprecipitation studies. When individually expressed in SF-21 cells, human p53 localized mainly in the nucleus whereas baculovirus p33 displayed diffuse cytoplasmic staining and punctuate nuclear staining. However, coexpression of p33 with p53 resulted in exclusive nuclear localization of p33. In both SF-21 and TN-368 cells, p53 expression induced typical features of apoptosis including nuclear condensation and fragmentation, oligonucleosomal ladder formation, cell surface blebbing, and apoptotic body formation. Coexpression of p53 with a baculovirus inhibitor of apoptosis, p35, OpIAP, or CpIAP, blocked apoptosis, whereas coexpression with p33 enhanced p53-mediated apoptosis approximately twofold. Expression of p53 in SF-21 cells stably expressing OpIAP inhibited cell growth in the presence or absence of p33. Thus, human p53 can influence both insect cell growth and death and baculovirus p33 can modulate the death-inducing effects of p53.

[1]  W. Kaiser,et al.  Inhibitor of Apoptosis Proteins Physically Interact with and Block Apoptosis Induced by Drosophila Proteins HID and GRIM , 1998, Molecular and Cellular Biology.

[2]  I. Garkavtsev,et al.  The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control , 1998, Nature.

[3]  L. Miller,et al.  Role of Baculovirus IE2 and Its RING Finger in Cell Cycle Arrest , 1998, Journal of Virology.

[4]  S. Seshagiri,et al.  Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  David P. Lane,et al.  Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo , 1997, Current Biology.

[6]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[7]  A. Harvey,et al.  Inhibition of reaper-induced apoptosis by interaction with inhibitor of apoptosis proteins (IAPs). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  V. Rotter,et al.  Involvement of p53 in cell differentiation and development. , 1997, Biochimica et biophysica acta.

[9]  L. Miller,et al.  Stable transformation of insect cells to coexpress a rapidly selectable marker gene and an inhibitor of apoptosis , 1997, In Vitro Cellular & Developmental Biology - Animal.

[10]  S. Seshagiri,et al.  Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced , 1997, Current Biology.

[11]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[12]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[13]  D. Livingston,et al.  Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.

[14]  D. Lacount,et al.  Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death , 1997, Journal of virology.

[15]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[16]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[17]  A. Harvey,et al.  Doom, a product of the Drosophila mod(mdg4) gene, induces apoptosis and binds to baculovirus inhibitor-of-apoptosis proteins , 1997, Molecular and cellular biology.

[18]  P. Branton,et al.  Regulation of apoptosis by viral gene products , 1997, Journal of virology.

[19]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[20]  P. Friesen,et al.  Role of early and late replication events in induction of apoptosis by baculoviruses , 1997, Journal of virology.

[21]  S. Srinivasula,et al.  Spodoptera frugiperda Caspase-1, a Novel Insect Death Protease That Cleaves the Nuclear Immunophilin FKBP46, Is the Target of the Baculovirus Antiapoptotic Protein p35* , 1997, The Journal of Biological Chemistry.

[22]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[23]  L. Miller,et al.  Induction of apoptosis by baculovirus transactivator IE1 , 1996, Journal of virology.

[24]  J. Bertin,et al.  Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease , 1996, Journal of virology.

[25]  M. Oren,et al.  p53 in growth control and neoplasia. , 1996, Biochimica et biophysica acta.

[26]  N. Horikoshi,et al.  Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor , 1996, Science.

[27]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[28]  K. Kinzler,et al.  Life (and death) in a malignant tumour , 1996, Nature.

[29]  J. Mankovich,et al.  Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. , 1995, Science.

[30]  D. Haber,et al.  The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. , 1995, Genes & development.

[31]  T. Hambuch,et al.  p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. , 1995, Oncogene.

[32]  A. Lu,et al.  The roles of eighteen baculovirus late expression factor genes in transcription and DNA replication , 1995, Journal of virology.

[33]  R. Tjian,et al.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.

[34]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[35]  D. Lane,et al.  Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides. , 1994, Oncogene.

[36]  R. J. Clem,et al.  Control of programmed cell death by the baculovirus genes p35 and iap , 1994, Molecular and cellular biology.

[37]  R. Possee,et al.  The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. , 1994, Virology.

[38]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[39]  B. Vogelstein,et al.  Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Harris,et al.  Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Q. Zhang,et al.  Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency , 1994, Molecular and cellular biology.

[42]  R. Russell,et al.  A 25-kDa protein is associated with the envelopes of occluded baculovirus virions. , 1993, Virology.

[43]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[44]  L. Szekely,et al.  EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[46]  M. Scheffner,et al.  Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 , 1993, Molecular and cellular biology.

[47]  P. Friedman,et al.  Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.

[48]  Bert Vogelstein,et al.  p53 function and dysfunction , 1992, Cell.

[49]  P. Friedman,et al.  Wild-type p53 activates transcription in vitro , 1992, Nature.

[50]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[51]  C. Marshall Tumor suppressor genes , 1991, Cell.

[52]  B. Vogelstein,et al.  Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Friedman,et al.  The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen , 1989, Cell.

[54]  K. Kinzler,et al.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression. , 1997, Molecular cell.

[55]  R. J. Clem Regulation of Programmed Cell Death by Baculoviruses , 1997 .

[56]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[57]  A. Berk,et al.  Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. , 1994, Genes & development.

[58]  D. O'reilly,et al.  Baculovirus expression vectors: a laboratory manual. , 1992 .

[59]  W. F. Hink,et al.  Established Insect Cell Line from the Cabbage Looper, Trichoplusia ni , 1970, Nature.